104 related articles for article (PubMed ID: 3698047)
1. Mitoxantrone and advanced squamous cell carcinoma of the cervix: a Southwest Oncology Group Study.
Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG
Cancer Treat Rep; 1986 Apr; 70(4):527-8. PubMed ID: 3698047
[No Abstract] [Full Text] [Related]
2. Mitoxantrone in advanced cervical carcinoma: a phase II study in patients not previously treated with chemotherapy.
Hørding U; Rose C; Jakobsen K; Dirksen H
Cancer Treat Rep; 1986 Oct; 70(10):1239-40. PubMed ID: 3756944
[No Abstract] [Full Text] [Related]
3. Activity of mitolactol in cancer of the uterine cervix.
Lira-Puerto V; Morales-Canfield F; Wernz J; Muggia FM
Cancer Treat Rep; 1984 Apr; 68(4):669-70. PubMed ID: 6713421
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
Muss HB; Sutton GP; Bundy B; Hatch KD
Am J Clin Oncol; 1985 Aug; 8(4):312-5. PubMed ID: 3909803
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
[No Abstract] [Full Text] [Related]
6. Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Stehman FB; Malfetano J
Cancer Treat Rep; 1986 Sep; 70(9):1127-8. PubMed ID: 3742494
[No Abstract] [Full Text] [Related]
7. Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group study.
Hilgers RD; Legha SS; Boutselis JG; Hannigan EV; Stephens RL; Tranum BL; Surwit E
Cancer Treat Rep; 1984 Feb; 68(2):443-4. PubMed ID: 6546533
[No Abstract] [Full Text] [Related]
8. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
9. Epirubicin and cisplatin in recurrent, metastatic or advanced carcinoma of the cervix.
Lorvidhaya V
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():252-5. PubMed ID: 7661592
[TBL] [Abstract][Full Text] [Related]
10. Continuous pelvic arterial infusion with bleomycin for squamous carcinoma of the cervix recurrent after irradiation therapy.
Morrow CP; DiSaia PJ; Mangan CF; Lagasse LD
Cancer Treat Rep; 1977 Oct; 61(7):1403-5. PubMed ID: 73418
[No Abstract] [Full Text] [Related]
11. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin versus adriamycin and bleomycin in advanced epidermoid carcinoma of the cervix.
Greenberg BR; Kardinal CG; Pajak TF; Bateman JR
Cancer Treat Rep; 1977 Oct; 61(7):1383-4. PubMed ID: 73417
[No Abstract] [Full Text] [Related]
13. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
[No Abstract] [Full Text] [Related]
15. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Homesley HD
Cancer Treat Rep; 1984 Dec; 68(12):1513-4. PubMed ID: 6509456
[No Abstract] [Full Text] [Related]
17. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
[No Abstract] [Full Text] [Related]
19. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
Gams RA; Nelson O; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
